CYP2U1 Gene SPG56 Genetic Test sale cost 4400 AED
ERLIN2 Gene SPG18 Genetic Test sale cost 4400 AED ERLIN2 Gene SPG18 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAJB2 Gene Spinal Muscular Atrophy Type 5 Genetic Test sale cost 4400 AED DNAJB2 Gene Spinal Muscular Atrophy Type 5 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CYP2U1 Gene SPG56 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP2U1 gene SPG56 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CYP2U1 gene, which have been associated with a rare neurological disorder known as spastic paraplegia 56 (SPG56). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness and contraction (spasticity) in the lower limbs. The CYP2U1 gene plays a crucial role in the nervous system’s development and function, and mutations in this gene can lead to the symptoms observed in SPG56.

The test is conducted at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the CYP2U1 gene. This test is critical for individuals with a family history of HSPs or those exhibiting symptoms of SPG56, as it can provide a definitive diagnosis of the condition.

The cost of the CYP2U1 gene SPG56 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, laboratory analysis, and a comprehensive report detailing the test results. It’s important for patients considering this test to consult with a healthcare provider or genetic counselor to understand the implications of the results and to discuss potential treatment options and management strategies for SPG56.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP2U1 Gene SPG56 Genetic Test

Cost: 4400.0 AED

Test Details

The CYP2U1 gene is associated with a condition called SPG56, which stands for Spastic Paraplegia Type 56. This genetic test uses Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the CYP2U1 gene and identify any variations or mutations that may be present.

SPG56 is a rare genetic disorder characterized by progressive stiffness and weakness in the legs (spastic paraplegia), leading to difficulty walking. Other symptoms may include muscle wasting, difficulty with balance, and, in some cases, intellectual disability or developmental delay.

The NGS genetic test for the CYP2U1 gene can help confirm a diagnosis of SPG56 in individuals with symptoms consistent with the condition. It can also be used for carrier testing in individuals with a family history of SPG56 or for prenatal testing in couples at risk of having a child with the condition.

The test involves collecting a DNA sample, typically through a blood or saliva sample, and then sequencing the CYP2U1 gene using NGS technology. The resulting DNA sequence is compared to a reference sequence to identify any variations or mutations. If a mutation or variation is identified in the CYP2U1 gene, it can help confirm a diagnosis of SPG56.

Genetic counseling may be recommended to help individuals understand the implications of the test results and discuss any family planning or treatment options.

It is important to note that this genetic test specifically analyzes the CYP2U1 gene and is not a comprehensive genetic test for all possible causes of spastic paraplegia. Other genes may also be involved in the development of this condition, and additional testing may be needed to identify any additional genetic factors.

Test Information

  • Components: CYP2U1 Gene SPG56 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for CYP2U1 Gene SPG56 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP2U1 Gene SPG56.
Test Name CYP2U1 Gene SPG56 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP2U1 Gene SPG56 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CYP2U1 Gene SPG56
Test Details

The CYP2U1 gene is associated with a condition called SPG56, which stands for Spastic Paraplegia Type 56. This genetic test uses Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the CYP2U1 gene and identify any variations or mutations that may be present.

SPG56 is a rare genetic disorder characterized by progressive stiffness and weakness in the legs (spastic paraplegia), leading to difficulty walking. Other symptoms may include muscle wasting, difficulty with balance, and, in some cases, intellectual disability or developmental delay.

The NGS genetic test for the CYP2U1 gene can help confirm a diagnosis of SPG56 in individuals with symptoms consistent with the condition. It can also be used for carrier testing in individuals with a family history of SPG56 or for prenatal testing in couples at risk of having a child with the condition.

The test involves collecting a DNA sample, typically through a blood or saliva sample, and then sequencing the CYP2U1 gene using NGS technology. The resulting DNA sequence is compared to a reference sequence to identify any variations or mutations.

If a mutation or variation is identified in the CYP2U1 gene, it can help confirm a diagnosis of SPG56. Genetic counseling may be recommended to help individuals understand the implications of the test results and discuss any family planning or treatment options.

It is important to note that this genetic test specifically analyzes the CYP2U1 gene and is not a comprehensive genetic test for all possible causes of spastic paraplegia. Other genes may also be involved in the development of this condition, and additional testing may be needed to identify any additional genetic factors.

SKU: TEST-2020 Category:

Related products